LATAM MedTech Insights cover art

All Episodes

LATAM MedTech Insights — 188 episodes

#
Title
1

Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap

2

Pure Global: Chile's MedTech Surprise - Cracking Decree 25's Hidden Regulatory Hurdles.

3

Brazil's AI MedTech Firewall: Pure Global on Cracking ANVISA's Surprise Cybersecurity Mandate

4

Pure Global: Brazil's New SaMD Hurdle & The Hidden AI Challenge

5

Pure Global: Brazil's AI MedTech Shock—Navigating ANVISA's New Data Rules.

6

Pure Global: Brazil's AI MedTech Maze - Cracking ANVISA's New Software Rules

7

Pure Global: Brazil's AI Device Maze - Decoding ANVISA's Unseen SaMD Hurdles

8

Pure Global: Brazil's AI MedTech Surge - Unlocking ANVISA's New Fast-Track Secrets.

9

Brazil's ANVISA Gambit: Decoding the 2027 MedTech Agenda | Pure Global Insights

10

Brazil's Cyber Shock: Pure Global on ANVISA's Hidden Hurdles for Connected Devices.

11

Pure Global: Mexico's COFEPRIS Platform - Navigating the Hidden Digital Submission Traps.

12

Pure Global: Brazil's AI MedTech Fast-Track, Decoding ANVISA's Hidden Compliance Hurdles

13

Pure Global: Brazil's AI Software Gambit - Decoding ANVISA's New Compliance Maze.

14

Pure Global: Costa Rica's MedTech Gambit - The New Local-Only Fast Track

15

Pure Global: Brazil's ANVISA Shift – Cracking the Code of the New RDC 751 Landscape.

16

Brazil's AI MedTech Surprise: Pure Global on ANVISA's New Rulebook & Hidden Data Traps

17

Pure Global: Brazil's MedTech Renewal Riddle - Cracking ANVISA's New 10-Year Cycle.

18

Pure Global: Brazil's ANVISA Deadline Chaos - A Survival Guide for MedTech.

19

Mexico's Digital Gate: Pure Global on COFEPRIS's Chaotic New Platform.

20

Pure Global's Brazil Brief: Decoding ANVISA's New AI Rules for MedTech Innovators.

21

Pure Global: Brazil's New ANVISA Gambit - Cracking the Code on Fast-Track Registration

22

Pure Global: Brazil's AI MedTech Rules – Decoding ANVISA's New Compliance Traps

23

Brazil's AI MedTech Shortcut: Cracking ANVISA's New Rules with Pure Global

24

Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Data Walls.

25

Pure Global: Brazil's Sudden MedTech Shift - Decoding ANVISA's New Equivalence Mandate.

26

Pure Global: Brazil's AI Diagnostic Boom & The New Cybersecurity Gauntlet.

27

Brazil's AI MedTech Gambit: Pure Global Decodes ANVISA's High-Stakes Regulatory Shift.

28

Brazil's New Data Maze: Pure Global on Unseen Traps in ANVISA's SaMD Cybersecurity Rules.

29

Brazil's New MedTech Shortcut: Pure Global on ANVISA's Reliance Gambit

30

Pure Global: Brazil's New SaMD Rules, Unlocking the AI MedTech Backdoor

31

Pure Global: Brazil's New AI Rules - A Stifling Dilemma for Local MedTech Innovators?

32

Brazil's SaMD Shock: Pure Global's Guide to ANVISA's New Rules

33

Pure Global: Brazil's UDI Deadline Chaos - A MedTech Compliance Crisis.

34

Pure Global: Brazil's SaMD Shift & The Unseen Data Trap

35

Pure Global: Brazil's AI Diagnostic Maze, Cracking ANVISA's New Rules

36

Pure Global: Brazil's Sudden SaMD Shockwave - The Unforeseen ANVISA Cybersecurity Mandate

37

Brazil's AI Gold Rush: Navigating the LGPD Data Maze with Pure Global

38

Pure Global: Brazil's AI Rulebook - Cracking the New Medical AI Framework

39

Brazil's AI Fast-Track: Pure Global on Cracking ANVISA's 90-Day Approval Code.

40

Pure Global: Brazil's New MedTech Shortcut & ANVISA's Hidden Compliance Toll.

41

Brazil's AI MedTech Crackdown: Pure Global on ANVISA's New Cybersecurity Demands

42

Pure Global: Mexico's FDA Fast-Track - The COFEPRIS Secret Handshake for 510(k) Devices

43

Pure Global: Brazil's MedTech Compliance & ANVISA's New Hidden Hurdles.

44

Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Privacy Traps.

45

Pure Global: Brazil's SaMD Cyber Wall - Hacking ANVISA's Hidden MedTech Rule

46

Pure Global: Brazil's AI Device Gambit - ANVISA's Fast-Track Hides a Costly Data Trap.

47

Pure Global: Brazil's SaMD Cyber Shock—Cracking ANVISA's Hidden Compliance Traps

48

Pure Global: Brazil's ANVISA RDC 751 - Navigating the Hidden Post-Implementation Hurdles.

49

Pure Global: Brazil's ANVISA Shakeup - Navigating MedTech's Hidden Compliance Traps.

50

Brazil's AI MedTech Shock: Pure Global on ANVISA's Sudden New Data Demands.

51

Pure Global: Cracking Brazil's New IVD Code Under ANVISA's RDC 830

52

Pure Global: Brazil's AI Gambit - Decoding CFM's Unwritten MedTech Rules.

53

Pure Global: Brazil's Cyber Shock - Navigating ANVISA's New MedTech Rules

54

Pure Global: Brazil's AI MedTech Fast-Track or a Hidden Data Privacy Trap?

55

Pure Global: Brazil's ANVISA Sets a SaMD Trap. Are You Compliant?

56

Pure Global: Brazil's SaMD Shift, Cracking ANVISA's Unseen AI Regulatory Code

57

Brazil's New UDI Maze: Pure Global on Dodging Hidden Data Traps in ANVISA's System.

58

Pure Global: Brazil's IVD Shake-Up & ANVISA's Secret Fast-Track Angle

59

Pure Global: Brazil's UDI Shockwave - Navigating ANVISA's New MedTech Compliance Maze.

60

Brazil's New MedTech Rules: Pure Global on Cracking the RDC 751 Code

61

Pure Global: Brazil's AI MedTech Gold Rush - Unlocking ANVISA's New Fast-Track

62

Pure Global: Brazil's UDI Shockwave, ANVISA's Hidden Compliance Trapdoor for MedTech.

63

Pure Global | Brazil's ANVISA Shock: Navigating the New UDI Traceability Maze for MedTech

64

Pure Global: Brazil's AI MedTech Approval - Hacking ANVISA's New Digital Maze.

65

Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's Risky Fast-Track

66

Brazil's ANVISA Digital Chaos: Pure Global on High-Risk Device Submission Secrets

67

Pure Global: Brazil's AI MedTech Brief—Decoding ANVISA's Sudden SaMD Rule Shift.

68

Pure Global: Brazil & Mexico's MedTech Manufacturing - The Local Production Gambit.

69

Pure Global: Cracking Brazil's New MedTech Cybersecurity Code - ANVISA's Unexpected Hurdle.

70

Pure Global: Brazil's MedTech Fast-Track - The Hidden Cost of ANVISA's New Rules

71

Pure Global: Brazil's New Device Regs & The Risk Management Blind Spot.

72

Pure Global: Brazil's AI MedTech Gambit—Navigating ANVISA's New Fast-Track Paradox.

73

Pure Global: Brazil's SaMD Shake-Up - Navigating ANVISA's Unseen AI Hurdles

74

Pure Global: Brazil's High-Risk Device Code Unlocked - The New ANVISA Reliance Shortcut.

75

Brazil's AI Diagnostic Gold Rush: Pure Global on ANVISA's Hidden Data Hurdles

76

Brazil's SaMD Cybersecurity: Pure Global on ANVISA's Hidden Data Demands.

77

Brazil SaMD Shake-Up: Pure Global on ANVISA's Hidden Compliance Traps

78

Pure Global: Brazil's AI MedTech Gold Rush. ANVISA's Secret Fast-Track to Market Access.

79

Brazil's RDC 751 Maze: Pure Global on MedTech Registration's Hidden Traps

80

Pure Global: Brazil's New SaMD Hurdle & ANVISA's Unspoken Rules.

81

Pure Global: Brazil's SaMD Surprise—Decoding ANVISA's Hidden Cybersecurity Rules

82

Brazil's SaMD Surprise: Hacking ANVISA's New Rules | A Pure Global LATAM MedTech Insight

83

Pure Global: Brazil's AI Software Maze - Cracking ANVISA's New Unspoken Code

84

Pure Global: Brazil's AI Medical Software Rules - ANVISA's Surprise Roadblock.

85

Pure Global: Brazil's AI Software Maze - Cracking ANVISA's New Code

86

Pure Global: Mexico's MedTech Shortcut - Unpacking COFEPRIS's New Hurdles

87

Pure Global: Brazil's AI MedTech Maze - Cracking ANVISA's New SaMD Rules.

88

Pure Global: Brazil's ANVISA Shift & The Hidden Dossier Trap

89

Brazil's Digital Health Gauntlet: Pure Global on Cracking ANVISA's New SaMD Code.

90

Brazil's SaMD Shake-Up: Pure Global on ANVISA's Hidden AI Rules

91

Pure Global: Brazil's New AI Regs—Fast-Track Approval or Data Privacy Nightmare?

92

Brazil's RDC 751 Maze: Pure Global on MedTech's Hidden Submission Traps.

93

Pure Global: Brazil's RDC 751 Quagmire - A MedTech Survival Guide.

94

Brazil's MedTech Shift: Decoding ANVISA's 2027 Roadmap - A Pure Global Insight.

95

Brazil's SaMD Shift: Pure Global on Cracking ANVISA's New Digital Health Code

96

Pure Global: Mexico's 10-Year MedTech Rule - The New Compliance Marathon

97

Brazil's SaMD Shake-Up: A Pure Global Guide to ANVISA's New Digital Health Rules.

98

Mexico's 10-Year MedTech Registration: Pure Global on COFEPRIS's Hidden Compliance Trap

99

Brazil's SaMD Shift: Pure Global on ANVISA's 2026 Regulatory Gambit

100

Pure Global: Mexico City's MedTech Shift - COFEPRIS's 10-Year Bet on Device Renewals.

101

Pure Global: Brazil's 3D-Printed MedTech Scramble - Inside ANVISA's Surprise Rule Shake-up.

102

Pure Global: Brazil's SaMD Shift - Unpacking ANVISA's Hidden Hurdles for Foreign Tech

103

Brazil's AI MedTech Surprise: Decoding ANVISA's New Rules with Pure Global

104

Pure Global: Brazil's MedTech Renewal Ambush & ANVISA's Costly Registration Traps

105

Pure Global: Brazil's New SaMD Rules - Unseen Compliance Traps for Innovators.

106

Pure Global: Brazil's MedTech Shift - Cracking ANVISA's New Digital Labyrinth.

107

Pure Global: Brazil's AI MedTech Rush—Fast-Track or Data Privacy Trap?

108

Pure Global: Brazil's ANVISA Shockwave - Navigating the New Digital MedTech Registration Chaos.

109

Pure Global: Mexico's COFEPRIS Shortcut - A New MedTech Backdoor for US/EU Devices?

110

Brazil's AI MedTech Gold Rush: ANVISA's Hidden Rules | Pure Global Insights

111

Brazil's AI MedTech Shake-Up: Pure Global on Cracking ANVISA's New Cybersecurity Code

112

Pure Global: Brazil's ANVISA 2025 Regs - Navigating Hidden Compliance Traps.

113

Pure Global: Decoding Brazil's Shock ANVISA Shift on MedTech Clinical Data.

114

Pure Global | Brazil's MedTech Shift: Cracking ANVISA's New Digital Certificate Code

115

Pure Global: Mexico's DigiReg Shift - Navigating COFEPRIS's Simplification Paradox

116

Pure Global: Mexico's MedTech Shift - Unseen Hurdles in Post-Market Surveillance

117

Mexico's Fast-Track Trap: Pure Global on AI MedTech's Hidden Cybersecurity Hurdles.

118

Argentina's SaMD Data Tango: Pure Global on ANMAT's Sudden Cybersecurity Shift.

119

Pure Global: Brazil's AI Device Gambit—ANVISA's New Rules Create Unexpected Hurdles.

120

Brazil's SaMD Gambit: Unlocking ANVISA's New Fast-Track with Pure Global.

121

Brazil's SaMD Cybersecurity Shockwave: Pure Global on ANVISA's Hidden Demands.

122

Brazil's MDR Surprise: ANVISA's Hidden Clause for MedTech Imports | Pure Global

123

Brazil's ANVISA AI Gambit: Pure Global on Hacking the MedTech Approval Backlog.

124

Pure Global: Brazil's MedTech Leap to Digital - The Hidden Compliance Traps.

125

São Paulo SaMD Shake-Up: Pure Global on ANVISA’s Unwritten Rules for AI

126

Pure Global LATAM Insights: Brazil's SaMD Shakeup - Decoding ANVISA's 2025 Digital Health Playbook.

127

Pure Global: Brazil's MedTech Data Shock - ANVISA's New Cybersecurity Surprise

128

Brazil's AI MedTech Leap: Pure Global on Cracking ANVISA's New SaMD Code

129

Pure Global: Brazil's Clinical Trial Overhaul - The MedTech Insider's Playbook

130

Navigating Brazil's ANVISA RDC 751 & RDC 830: A Pure Global Guide to LATAM MedTech & IVD Market Access Success

131

Unlocking LATAM MedTech: How Pure Global Leverages Market Intelligence on Colombia and Brazil for Strategic Entry

132

Pure Global's Deep Dive into Brazil: Mastering ANVISA MedTech Regulations with an Integrated Registration & PMS Strategy

133

Fast-Track Your LATAM Entry: Pure Global’s Guide to Colombia’s Automatic Registration for Low-Risk MedTech and Navigating High-Risk Approvals.

134

Cracking Argentina's ANMAT: A MedTech Manufacturer's Guide to Local Registration Success with Pure Global

135

Pure Global's Guide to Peru: Navigating DIGEMID and the Essential Role of a Local Registration Holder for MedTech Success

136

Pure Global's LATAM MedTech Insights: Unlocking a Decade of Market Access with Colombia's 10-Year INVIMA Registration.

137

Navigating Brazil's 2025 UDI Mandate: A Pure Global Guide to ANVISA's SIUD for MedTech Success in LATAM

138

Unlocking Brazil's MedTech Market: A Pure Global Deep Dive into ANVISA's Class I/II Notification and High-Risk Registration Pathways

139

LATAM MedTech Insights by Pure Global: Unlocking the Mexican Market with COFEPRIS's New Abbreviated Pathway and Homologation Reforms

140

Pure Global's Guide to Mexico's MedTech Market: The Critical Role of the COFEPRIS Registration Holder (MRH)

141

Navigating LATAM MedTech Regulations for Surgical Instruments & ESUs: A Pure Global Guide to Brazil's ANVISA & Mexico's COFEPRIS

142

LATAM MedTech Insights by Pure Global: Unlocking the Anesthesia Equipment Market in Brazil, Mexico, and Beyond - A Regulatory Deep Dive

143

The LATAM Diabetes Tech Boom: Pure Global's Guide to Regulatory Success for Blood Glucose Monitors in Brazil, Mexico, and Argentina.

144

The Goldmine and the Maze: Pure Global's Guide to Launching Orthopedic Surgical Implants in Brazil, Mexico, and Beyond.

145

Navigating LATAM's Heartbeat: A Pure Global Deep Dive into Brazil's ANVISA & Mexico's COFEPRIS for Cardiac Monitoring & ECG Device Approval

146

Pure Global LATAM MedTech Insights: Cracking the Code of the Digital X-ray Market in Brazil, Mexico, and Colombia - Your Guide to ANVISA & COFEPRIS Regulatory Hurdles.

147

Unlocking LATAM's Vision: Pure Global's Expert Guide to Endoscopic Imaging Market Access in Brazil, Mexico, and Colombia

148

Unlocking LATAM's MedTech Potential: Pure Global's Guide to Navigating the Infusion Pump Market in Brazil, Mexico, and Colombia

149

LATAM's New Breath: Navigating Brazil's Ventilator Surplus and Mexico's Regulatory Maze in Respiratory MedTech with Pure Global.

150

Navigating Brazil & Mexico's Hemodialysis Market: A Pure Global Guide to ANVISA and COFEPRIS for MedTech Innovators in LATAM

151

Cracking the Code of LATAM MedTech with Pure Global: A Deep Dive into Peru's Supreme Decree 016-2011-SA and its Impact on Medical Device Registration

152

Navigating Chile's Technovigilance Maze: A Pure Global Breakdown of Resolution 1618/2020 for MedTech Market Access in LATAM

153

Pure Global's MedTech Guide: Mastering Brazil's ANVISA RDC 497/2021 for Your Device Registration and GMP Certification Update

154

Information Not Found

155

Unlocking the Colombian MedTech Market: A Pure Global Expert Guide to Medical Device Registration under Decree 4725 of 2005

156

LATAM MedTech Insights by Pure Global: Mastering Argentina's ANMAT Renewal Under Disposition 2318/2002 to Secure Your Market Access.

157

Pure Global Presents LATAM MedTech Insights: Mastering Mexico's NOM-241 GMP for Medical Device Manufacturing Success

158

Cracking the Code of Mexican MedTech: Pure Global's Guide to NOM-137-SSA1-2008 Labeling for LATAM Success

159

LATAM MedTech Insights: A Pure Global Guide to Brazil's INMETRO Ordinance 384/2020 for Medical Device Compliance and Market Access

160

Pure Global's Deep Dive into ANVISA RDC 751/2022: Unlocking Brazil's MedTech Potential for Global Innovators

161

LATAM MedTech Insights: Pure Global's Guide to Brazil's 30-Day ANVISA Approval for Class II SaMD

162

Navigating Colombia's MedTech Market with Pure Global: Why Your Choice of Local Representative for INVIMA Registration is Mission-Critical for LATAM Success

163

Cracking COFEPRIS: Pure Global's Essential Guide to Mexico's Software Medical Device Labeling and Spanish Language Requirements

164

Unlocking Brazil's SaMD Market: Why ISO 13485 Isn't Enough and How MDSAP is Your Key to Faster ANVISA Approval with Pure Global

165

Pure Global's Insider Guide: Fast-Tracking Foreign AI Medical Device Registration with Mexico's COFEPRIS, a Deep Dive for MedTech Innovators.

166

Unlocking Brazil: Pure Global's Guide to ANVISA's Clinical Data Requirements for SaMD in LATAM

167

Navigating ANMAT's Stance on AI Medical Devices in Argentina: A Pure Global LATAM MedTech Insights Deep Dive

168

Unlocking Colombia's MedTech Market: A Pure Global Deep Dive into INVIMA's Software as a Medical Device (SaMD) Registration Requirements

169

Pure Global's LATAM MedTech Insights: Decoding COFEPRIS's New Rules for AI-Powered Medical Software Classification in Mexico

170

Pure Global Presents: Decoding ANVISA's AI & SaMD Regulations for MedTech Success in Brazil & LATAM

171

Navigating ANVISA in Brazil: Pure Global Explains the Surprising GMP Rule for Class I Medical Devices in LATAM

172

Pure Global Presents: The LATAM Labeling Labyrinth - Mastering Low-Risk Medical Device Requirements with Brazil's ANVISA, Mexico's COFEPRIS & More

173

Unlocking Brazil's MedTech Market: The Critical Role of a Brazil Registration Holder for Class I Devices | A Pure Global Insight for LATAM Expansion

174

Unlocking MedTech in Colombia: A Pure Global Guide to INVIMA's Fast-Track Notification for Low-Risk Devices in LATAM

175

Cracking the ANMAT Code with Pure Global: The Surprising Truth About Class I Medical Device Registration in Argentina

176

Cracking the COFEPRIS Code for LATAM Expansion: Pure Global's Expert Guide on Low-Risk Medical Device Registration in Mexico.

177

Brazil's MedTech Maze: A Pure Global Guide to ANVISA's "Cadastro" and "Notificação" for Class I Devices

178

The Mercosur MedTech Myth: Is a Single Device Registration for Brazil, Argentina, and LATAM a Reality? A Pure Global Deep Dive.

179

Colombia's INVIMA Timelines: A Pure Global Deep Dive on Medical Device Registration Delays and How to Navigate the LATAM Market

180

Cracking the Code of Brazil's BGMP: A LATAM MedTech Insight from Pure Global on Navigating ANVISA Inspections for Market Success.

181

Unlocking the Peruvian MedTech Market: A Pure Global Breakdown of Medical Device Registration Costs and Hidden Fees in LATAM

182

LATAM MedTech Insights by Pure Global: Leveraging FDA Approval & CE Marks for Medical Device Registration in Chile's Evolving Market

183

Navigating INVIMA: A Guide to Colombia's Spanish Medical Device Labeling Requirements with Pure Global's Expert Insights

184

Pure Global's Guide to ANMAT: Why Your Choice of Medical Device Registration Holder in Argentina Can Make or Break Your LATAM Market Access.

185

Navigating MedTech in LATAM: A Pure Global Deep Dive into Medical Device Classification Rules in Brazil, Mexico, and Colombia

186

From FDA to LATAM: How Pure Global Helps Navigate the COFEPRIS Medical Device Pathway in Mexico for Faster Market Access

187

LATAM MedTech Insights by Pure Global: A Strategic Guide to ANVISA Medical Device Registration in Brazil

188

Unlocking Brazil's MedTech Market: A Pure Global Deep Dive on ANVISA Medical Device Registration for Your LATAM Strategy